Heart doctors question beta blockers' benefit for heart attack survivors after 40 years of use

scitechdaily.com

Beta blockers, a standard heart attack treatment for 40 years, may offer no benefit and potentially increase risks for women, according to the REBOOT trial. The REBOOT trial found no improvement in outcomes for heart attack survivors with preserved heart function. A substudy indicated women treated with beta blockers faced higher risks of death or further cardiac events. This large, independently funded study challenges long-standing cardiology practices and is expected to reshape international clinical guidelines for heart attack care.


With a significance score of 4.5, this news ranks in the top 2.4% of today's 28457 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Heart doctors question beta blockers' benefit for heart attack survivors after 40 years of use | News Minimalist